RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:2460

Van den Ende-Gupta syndrome

medium confidenceDisorder

Also known as: Marden-Walker-like syndrome · VDEGS

Publications

417

76.6th percentile

Trials

0

Interventional, condition-specific

Researchers

635

Distinct authors in sample

Gene link

SCARF2

Definitive

Readiness

3/6

Stages with a signal

Clinical definition (Orphanet)

Van den Ende-Gupta syndrome is a very rare syndrome characterized by blepharophimosis, arachnodactyly, joint contractures, and characteristic features.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (1)

van den Ende-Gupta syndrome

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

3/6 stages with a signal

No matched interventional trial; the gene is known and literature exists — preclinical or natural-history work may still be the practical next step.

  1. Gene identifiedPresent

    Definitive — SCARF2

  2. LiteraturePresent

    417 matched papers (312 in last 10 years) Source

  3. Phenotype characterisedPresent

    101 HPO annotations (e.g. Dislocated radial head; 2-3 toe syndactyly; Depressed nasal bridge) Source

  4. Animal modelNot found

    No Alliance genotype “model of” associations via Monarch for these Mondo IDs

  5. Orphan designationNot found

    No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source

  6. Interventional trialNot found

    No matched interventional trial under our ClinicalTrials.gov rules

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Yes — we know a specific gene responsible (SCARF2).

GenCC classification: Definitive.

Phenotypes (Monarch / HPO)

101

Associated phenotypes · MONDO:0010959

  • Dislocated radial head
  • 2-3 toe syndactyly
  • Depressed nasal bridge
  • Slender metacarpals
  • Bowing of the long bones

Showing 5 of 101 — open Monarch for the full list.

Animal models (Monarch / Alliance)

None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.

Open Targets candidates

No drugs or clinical candidates returned for this Mondo ID on Open Targets.

CTD chemicals (MyDisease.info)

No CTD chemical associations returned for this Mondo ID.

Literature

Is anyone studying this?

417

417 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

417 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

312 in the last 10 years · medium confidence · 76.6th percentile (publications denominator)

Phrase hits: 85 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

635

Distinct author names in 85 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    McDonald-McGinn DM8 papers · 2023

    Division of Human Genetics, The Children’s Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

    Papers in Europe PMC
  2. 02
    Emanuel BS7 papers · 2023

    Division of Genetics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

    Papers in Europe PMC
  3. 03
    Zackai EH5 papers · 2023

    The 22q and You Center, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

    Papers in Europe PMC
  4. 04
    Hytönen MK4 papers · 2021

    Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.

    Papers in Europe PMC
  5. 05
    Lohi H4 papers · 2021

    Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland. hannes.lohi@helsinki.fi.

    Papers in Europe PMC
  6. 06
    Vermeesch JR4 papers · 2018

    Center for Human Genetics, Katholieke Universiteit Leuven (KU Leuven), Leuven, Belgium.

    Papers in Europe PMC
  7. 07
    Ali R3 papers · 2018

    Section of Clinical and Metabolic Genetics, Department of Pediatrics, Hamad Medical Corporation, Doha, Qatar.

    Papers in Europe PMC
  8. 08
    Alkuraya FS3 papers · 2023

    Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. falkuraya@kfshrc.edu.sa.

    Papers in Europe PMC
  9. 09
    Arumilli M3 papers · 2021

    Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.

    Papers in Europe PMC
  10. 10
    Ben-Omran T3 papers · 2018

    Section of Clinical and Metabolic Genetics, Department of Pediatrics, Hamad Medical Corporation, Doha, Qatar.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).

Data as of 11 September 2026 · last trial check 11 September 2026

No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.

medium confidence · 38.6th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-29

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for Van den Ende-Gupta syndrome — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

("Van den Ende-Gupta syndrome" OR "Marden-Walker-like syndrome" OR "VDEGS") OR ("SCARF2" OR "SCARF2 syndrome" OR "SCARF2-related")

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Van den Ende-Gupta syndrome" OR "Marden-Walker-like syndrome" OR "VDEGS"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus
  • Publication count (417) is high for prevalence class "<1 / 1 000 000" — confidence capped at medium

Ingested 2026-07-26T20:13:03.687Z